Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. ProRx, LLC
WARNING LETTER
•ProRx, LLC•August 2, 2024

ProRx, LLC – FDA Warning Letter, Aug 2, 2024

Record Details

On December 20, 2024, the FDA issued Warning Letter #696742 to ProRx, LLC, an outsourcing facility located in Exton, Pennsylvania, following an inspection from July 15 to August 2, 2024. The inspection revealed that ProRx, LLC's drug products failed to meet the conditions of section 503B of the FDCA, necessary for exemptions from certain provisions, and exhibited serious deficiencies in sterile drug production, posing patient risks.

Key violations include: - **Failure to meet 503B conditions:** Compounding drugs using bulk substances from an unregistered establishment, inadequate labeling (missing "This is a compounded drug," facility information, established drug name, dosage form, "Office Use Only," and ingredient lists), and insufficient adverse event reporting procedures (lacking definitions for "serious" and "unexpected" events, 15-day reporting requirements, follow-up investigation requirements, and proper reporting methods). - **Adulterated Drug Products (Insanitary Conditions):** Observations included operators blocking first-pass air over uncapped vials, rapid movements near sterile products, bare hands exposed in ISO 5 areas, improper gowning, powering off ISO 5 Biosafety Cabinet (BSC) during cleaning, use of non-sterile wipes, inadequate media fills, no environmental monitoring in ISO 5, insufficient smoke studies, and a flying insect in cleanroom areas.

Company
ProRx, LLC
Inspection date
August 2, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • F. Gail Bormel (F.)
View Company Profile

ID · bf271e13-449a-47b3-9d62-0b8f47da4717

Violation Codes10
FD&C Act 501(a)(2)(B)21 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.166(a)21 CFR 211.22(d)21 U.S.C. 351(a)(2)(A)21 CFR 210.1(b)21 CFR 200.10(b)21 CFR 211.42(c)(10)(v)21 CFR 201.115

Full citation text and observation details available on the Dashboard.

Other documents for ProRx, LLC
  • WARNING_LETTER - 2024-08-02August 2, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ProRx, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.